A 20-year-old cancer vaccine may hold the key to long-term survival

More than two decades ago, a small group of women with advanced breast cancer took part in a clinical trial that tested an experimental vaccine. All these years later, every one of them is still alive. Researchers say survival over such a long period is extremely uncommon for people with metastatic breast cancer, which is why the case drew renewed scientific attention.

1. Homepage
2. Science
3. A 20-year-old cancer vaccine may hold the key to long-term survival